A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)
- Published in:
- Human Vaccines & Immunotherapeutics, 2020, v. 16, n. 11, p. 2634, doi. 10.1080/21645515.2020.1743122
- By:
- Publication type:
- Article